| 000 | 01059 a2200289 4500 | ||
|---|---|---|---|
| 005 | 20250516064732.0 | ||
| 264 | 0 | _c20120110 | |
| 008 | 201201s 0 0 eng d | ||
| 022 | _a1526-632X | ||
| 024 | 7 |
_a10.1212/WNL.0b013e31823c1200 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRammohan, Kottil W | |
| 245 | 0 | 0 |
_aDisease activity return during natalizumab treatment interruption in patients with multiple sclerosis. _h[electronic resource] |
| 260 |
_bNeurology _cNov 2011 |
||
| 300 |
_a1930; discussion 1930-1 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Comment | ||
| 650 | 0 | 4 |
_aAntibodies, Monoclonal _xadverse effects |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMultiple Sclerosis, Relapsing-Remitting _xdrug therapy |
| 700 | 1 | _aOrtega, Milissa R | |
| 700 | 1 | _aDelgado, Silvia R | |
| 700 | 1 | _aTornes, Leticia | |
| 773 | 0 |
_tNeurology _gvol. 77 _gno. 21 _gp. 1930; discussion 1930-1 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1212/WNL.0b013e31823c1200 _zAvailable from publisher's website |
| 999 |
_c21332800 _d21332800 |
||